Generation of donor-specific immunotolerance in renal-allograft recipients

The kidney cannot be successfully grafted without immunosuppressive therapy. A unicenter retrospective study has evaluated the efficiency of immunosuppression with daclizumab (Zenapax) versus alemtuzumab (Campath).Subjects and methods. After renal allotransplantation, 64 patients, including 34 and 3...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: V. A. Goryainov, M. M. Kaabak, M. M. Morozova, L. A. Shishlo, N. N. Babenko, A. K. Zokoyev
Médium: Artigo
Jazyk:Inglês
Vydáno: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Edice:Transplantologiâ
Témata:
(allogenic) renal transplantation
immunosuppression
comparative study
campath
zenapax
On-line přístup:https://www.jtransplantologiya.ru/jour/article/view/240
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky